Literature DB >> 18343536

Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.

A V Atrasheuskaya1, M V Kulak, A A Neverov, S Rubin, G M Ignatyev.   

Abstract

While the proportion of measles cases in vaccinees is expected to increase as vaccine coverage increases, such cases must be carefully investigated. The present study was conducted to examine possible contributions to vaccine failures (VFs) and to genetically characterize measles virus (MV) strains circulating in Novosibirsk, Russia during 2000-2005. Totally, 27 adult measles patients admitted to a regional hospital were prospectively enrolled in our study. Genetic characterization of the MV strains revealed circulation of genotypes A, D4 and D6 between 2000 and 2003 years; a genotype D6 MV was associated with the 2005 measles outbreak. Based on IgG avidity testing, half of the vaccinated patients demonstrated evidence of secondary vaccine failure (SVF). Patients, representing both levels of vaccine failure in our study were characterized by the lack of protective titers of neutralizing antibodies against circulating MVs, despite high IgG levels in many cases and high IgG avidity in SVF cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343536     DOI: 10.1016/j.vaccine.2008.02.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Factors associated with delayed measles vaccination among children in Shenzhen, China: a case-control study.

Authors:  Weiyan Lin; Yongzhen Xiong; Hao Tang; Baoli Chen; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Improving molecular tools for global surveillance of measles virus.

Authors:  Bettina Bankamp; Lauren A Byrd-Leotis; Elena N Lopareva; Gibson K S Woo; Chunyu Liu; Youngmee Jee; Hinda Ahmed; Wilina W Lim; Nalini Ramamurty; Mick N Mulders; David Featherstone; William J Bellini; Paul A Rota
Journal:  J Clin Virol       Date:  2013-06-24       Impact factor: 3.168

Review 3.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

4.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

Review 5.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

6.  Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections.

Authors:  Nicklas Sundell; Leif Dotevall; Martina Sansone; Maria Andersson; Magnus Lindh; Thomas Wahlberg; Tobias Tyrberg; Johan Westin; Jan-Åke Liljeqvist; Tomas Bergström; Marie Studahl; Lars-Magnus Andersson
Journal:  Euro Surveill       Date:  2019-04

7.  Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.

Authors:  Hana Saffar; Maryam Khalifeloo; Mohammad-Jafar Saffar; Alireza Abdollahi; Mohammad-Reza Parsaei; Gholam-Reza Ghorbani; Samaneh Salarvand; Mohsen Aarabi
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

Review 8.  Breakthrough Infections: A Challenge towards Measles Elimination?

Authors:  Clara Fappani; Maria Gori; Marta Canuti; Mara Terraneo; Daniela Colzani; Elisabetta Tanzi; Antonella Amendola; Silvia Bianchi
Journal:  Microorganisms       Date:  2022-08-04

9.  Molecular Epidemiology of Measles Virus before and after the 2003 Mass Vaccination Campaign for Measles/Rubella in Iran.

Authors:  M Naseri; V Salimi; T Mokhtari-Azad; A Esteghamati; Mm Gooya; Sa Nadji; Z Noroozbabaei; Sm Marashi; Z Saadatmand; F Rezaei; R Hamkar; H Triki
Journal:  Iran J Public Health       Date:  2011-03-31       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.